Literature DB >> 21191508

Why all prostate cancer surgery should include an adequate lymph node dissection.

D Robert Siemens1.   

Abstract

Entities:  

Year:  2010        PMID： 21191508      PMCID： PMC2997840          DOI： 10.5489/cuaj.10185

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  34 in total

1.  Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.

Authors:  Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Vincenzo Scattoni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2006-02-17       Impact factor: 20.096

2.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

3.  Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.

Authors:  Alberto Briganti; Felix K-H Chun; Andrea Salonia; Nazareno Suardi; Andrea Gallina; Luigi Filippo Da Pozzo; Marco Roscigno; Giuseppe Zanni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2006-08-31       Impact factor: 20.096

4.  Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.

Authors:  Jun Kawakami; Maxwell V Meng; Natalia Sadetsky; David M Latini; Janeen Duchane; Peter R Carroll
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

Review 5.  Adjunctive therapy for men with high risk localized and locally advanced prostate cancer: targeting disseminated tumor cells.

Authors:  Mitchell H Sokoloff; Carrie W Rinker-Schaeffer; Leland W K Chung; Charles B Brendler
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

6.  Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic.

Authors:  K Weingärtner; A Ramaswamy; A Bittinger; E W Gerharz; D Vöge; H Riedmiller
Journal:  J Urol       Date:  1996-12       Impact factor: 7.450

7.  Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques.

Authors:  N N Stone; R G Stock; P Unger
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

8.  Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.

Authors:  Danil V Makarov; Bruce J Trock; Elizabeth B Humphreys; Leslie A Mangold; Patrick C Walsh; Jonathan I Epstein; Alan W Partin
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

9.  The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.

Authors:  Timothy A Masterson; Fernando J Bianco; Andrew J Vickers; Christopher J DiBlasio; Paul A Fearn; Farhang Rabbani; James A Eastham; Peter T Scardino
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

10.  Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.

Authors:  Jose A Karam; Robert S Svatek; Pierre I Karakiewicz; Andrea Gallina; Claus G Roehrborn; Kevin M Slawin; Shahrokh F Shariat
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531
View more
  1 in total

1.  Prevalence of lymph node metastasis in radical prostatectomy; a retrospective and multicenter study in iran.

Authors:  Mohsen Ayati; Mohammad Reza Nowroozi; Hassan Jamshidian; Elnaz Ayati; Farhad Zarghan
Journal:  Iran J Med Sci       Date:  2014-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.